EUVIMEDEUVIMED entdecken
Crossref

Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database

Heng Chen, Guoping Yang, Junlong Ma iD

International Journal of Cancer · 2024-05 · 154 (9) · 1616-1625

DOI: 10.1002/ijc.34848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 12.01.2024. Verfasst von Heng Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, the Key Research and Development Project of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti‐human epidermal growth factor receptor 2 (HER2) agents have exhibited pronounced tumor‐inhibitory activity, yet the accompanying ocular toxicity has frequently been underestimated. We aim to conduct a comprehensive comparative analysis of ocular toxicity risk related to various anti‐HER2 agents. We executed a retrospective pharmacovigilance investigation based on the FDA Adverse Event Reporting System (FAERS) database, covering the period from Q2 2018 to Q1 2023. The disproportionality analysis was performed to assess ocular toxicity risk. Multivariate logistic regression was implemented to mitigate potential biases. Moreover, the time to onset of ocular toxicity was also evaluated. A total of 3467 ocular adverse event (AE) reports concerning anti‐HER2 agents were collected. At the preferred term (PT) level, there were 69 positive signals, among which excessive eye blinking, abnormal sensation in the eye, and asthenopia presented a significant risk. In comparison to tyrosine kinase inhibitors (TKIs), antibody drugs were associated with a broader range of ocular disorders at Standardized MedDRA Queries (SMQ)levels, including conjunctival disorders, corneal disorders, ocular infections, ocular motility disorders, optic nerve disorders, and retinal disorders. In terms of onset time, pertuzumab displayed an earlier onset at 21.5 days, while trastuzumab deruxtecan had the latest at 91.5 days. In summary, our study reveals varying degrees of ocular toxicity related to anti‐HER2 agents, with a significantly higher risk observed in antibody drugs. Additionally, novel ocular toxicity signals, not documented in product labels, have been detected. In the future, further research will be necessary to validate our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleToxic Optic NeuropathyPharmacovigilanceRetrospective StudiesDatabases, FactualAdverse Drug Reaction Reporting Systems

Stichwörter der Autor:innen

FAERSanti-HER2 agentsbreast cancerocular toxicitypharmacovigilance

Autor:innen und Institutionen

  • Department of Pharmacy, The First Hospital of Changsha, Changsha, Hunan, China.
  • Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

ORCID-Profile: Junlong Ma

Förderung

  • Natural Science Foundation of Hunan Province
  • the Key Research and Development Project of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, H., Yang, G., & Ma, J. (2024). Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database. International Journal of Cancer, 154(9), 1616-1625. https://doi.org/10.1002/ijc.34848

Vancouver

Chen H, Yang G, Ma J. Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database. International Journal of Cancer. 2024;154(9):1616-1625. doi:10.1002/ijc.34848

BibTeX
@article{Chen2024,
  author = {Chen, Heng and Yang, Guoping and Ma, Junlong},
  title = {Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {154},
  number = {9},
  pages = {1616--1625},
  doi = {10.1002/ijc.34848}
}
Kostenlos starten →